Thus, in patients with OA who did not suffer from COVID-19, established a decrease in the levels of VEGF by 34.3%, FGF-2 by 26.2% and PDGF by 39.7%, compared to healthy control (p ≤ 0.001). This evidence concerns the gene VEGFA and COVID-19.